By AMIE TSANG
The experimental drug ofatumumab would bolster the Swiss pharmaceutical company’s portfolio of multiple sclerosis treatments.
Published: August 22, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1NzuimJ
from WordPress http://ift.tt/1hPCymr
via Hadi Aboukhater
No comments:
Post a Comment